Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs
Stockchase Opinions

Jason Snipe, CIO, Odyssey Capital AdvisorsAlnylam PharmaceuticalsALNYBUYJun 24, 2024

Positive results of their heart disease drug lifted shares today. M&A in this space and declining interest rates have been positive. We'll see what happens here. Drug pricing is always an issue in election years, but he thinks this will do well this year.

$222.82

Stock price when the opinion was issued

$274.95

As of Jun 18, 2026. Market Open.

biotechnology
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.